• GTP Solution: A Translational mRNA Framework

  2026-09-02

  GTP Solution (100 mM) connects nucleotide control with reliable in vitro transcription and translational mRNA research. This article develops an assay-stage framework for interpreting p21 mRNA–LNP results in localized bladder cancer models without conflating RNA quality, delivery, and tumor biology.

• Pravastatin Sodium: From Lipid Biology to Translation

  2026-09-02

  A translational framework for using pravastatin sodium to connect HMG-CoA reductase biology, cholesterol biosynthesis inhibition, transporter-aware hepatocyte studies, and cardiovascular or oncology research.

• Fosinopril Sodium: From PK to Assay Design

  2026-09-01

  Fosinopril sodium is an ACE inhibitor whose prodrug activation and dual elimination create important assay-design considerations. This guide connects pharmacokinetics, zinc-dependent inhibition, and translational readouts for more interpretable hypertension research.

• WSP-5 for Rapid H2S Live-Cell Imaging

  2026-08-31

  WSP-5, also called Washington State Probe-5, is a reaction-based turn-on fluorescent probe for selective H2S detection. Its rapid optical response supports live-cell imaging of hydrogen sulfide and monitoring H2S dynamics in cells, while disease-mechanism conclusions require independent biological validation.

• Spatial Metabolomics of Hippocampal Lipids in POCD

  2026-08-31

  A 2024 rat study used spatial metabolomics to map hippocampal lipid disturbances after cardiopulmonary bypass and linked CA1 lipid accumulation to altered iPLA2 and SPT signals, synaptic injury, and cognitive dysfunction. The findings position lipid-pathway modulation, including SPT inhibition, as a testable strategy for postoperative cognitive dysfunction research while highlighting important limits in causal and clinical interpretation.

• EdU Imaging Kits (Cy3) in Fibroblast Research

  2026-08-30

  EdU Imaging Kits (Cy3) provide denaturation-free visualization of DNA synthesis in proliferating fibroblasts. This article explains how a 5-ethynyl-2'-deoxyuridine imaging kit can strengthen mechanistic studies of nanoplastic-induced pulmonary fibrosis while clarifying assay limitations and interpretation.

• AZD8055 Technical Guide for mTOR Inhibition

  2026-08-29

  AZD8055 (SKU A8214) is a selective ATP-competitive mTOR inhibitor for dissecting mTORC1 and mTORC2 activity in cellular and preclinical models. It is best used for mechanistic cancer and metabolism studies, not as a substitute for clinical efficacy evidence or for workflows requiring water-soluble compounds.

• Sodium Nitroprusside for Sex-Aware Vascular Assays

  2026-08-28

  Use Sodium Nitroprusside as a controlled nitric oxide donor to separate vascular smooth muscle responsiveness from autonomic and hormone-dependent blood-pressure regulation. This workflow connects ex vivo relaxation and platelet assays with the sex-specific telemetry findings reported in angiotensin II hypertension research.

• CX-5461 RNA Polymerase I Inhibitor Workflow

  2026-08-28

  CX-5461 gives cancer research teams a mechanistically defined way to disrupt Pol I-driven rRNA synthesis, then distinguish growth arrest, autophagy, senescence, DNA damage, and mitotic catastrophe. This workflow translates its use from solid-tumor screening into cervical cancer combination studies with cisplatin.

• Partial BACE Inhibition and Synaptic Transmission

  2026-08-28

  Satir et al. examined whether moderate β-secretase inhibition can reduce amyloid-beta secretion without disrupting synaptic transmission, using primary cortical rat neurons and optical electrophysiology. The study found that reductions of less than 50% were not associated with impaired synaptic transmission, whereas stronger inhibition reduced both amyloid-beta secretion and synaptic activity, supporting exposure-sensitive strategies in Alzheimer’s disease research.

• Estradiol Benzoate: From Binding to Translation

  2026-08-27

  A mechanistic and strategic guide to using Estradiol Benzoate as an estrogen receptor alpha agonist, connecting receptor engagement, assay design, product quality, and translational decision-making without overstating what binding data can prove.

• A40926: Workflows for Glycopeptide Assays

  2026-08-26

  A40926 is a dalbavancin precursor that connects mechanistic cell-wall research with practical susceptibility, resistance, and fermentation workflows. This guide translates its organism-specific potency and engineered-production data into assay setup, optimization, and troubleshooting decisions.

• A40926: Dalbavancin Precursor and Glycopeptide

  2026-08-26

  A40926 is a natural glycopeptide antibiotic and dalbavancin precursor that inhibits peptidoglycan assembly by binding D-alanyl-D-alanine termini. Its research value includes Gram-positive bacterial infection research, MRSA research, and Neisseria gonorrhoeae inhibition, with activity that depends on organism, molecular form, and assay conditions.

• Tubastatin A in Porcine Cardiac Arrest Injury

  2026-08-26

  A 2025 porcine study evaluated Tubastatin A after cardiac arrest and resuscitation, linking improved myocardial function with reduced GSDME-associated pyroptosis, MLKL-associated necroptosis, and inflammatory signaling. Its large-animal design provides a clinically relevant framework for studying HDAC6 inhibition in acute ischemia–reperfusion injury while leaving direct target engagement and long-term translation unresolved.

• Engineered Nonomuraea Boosts A40926 Production

  2026-08-25

  This study combined targeted modification of the A40926 biosynthetic gene cluster with statistical medium optimization in Nonomuraea gerenzanensis. The results show that coordinated genetic engineering and fermentation design can substantially improve production of A40926, a dalbavancin precursor, while also illustrating the limits of transferring shake-flask findings directly to industrial manufacturing.

452 records 6/31 page Previous Next First page 上5页 678910 下5页 Last page